4//SEC Filing
Calise Chris 4
Accession 0001683168-23-006200
CIK 0001759186other
Filed
Aug 30, 8:00 PM ET
Accepted
Aug 31, 4:01 PM ET
Size
6.5 KB
Accession
0001683168-23-006200
Insider Transaction Report
Form 4
Calise Chris
Director
Transactions
- Purchase
Common Stock
2023-08-23$0.94/sh+9,000$8,460→ 1,462,315 total - Purchase
Common Stock
2023-08-23$0.94/sh+2,582$2,419→ 1,464,897 total
Footnotes (1)
- [F1]Includes (i) 942,117 shares of common stock that are issuable under currently exercisable options and (ii) 7,500 shares of common stock that are issuable upon exercise of options that will become exercisable. Does not include 22,500 shares of common stock that are issuable upon exercise of options that are not currently exercisable and will not become exercisable in the next 60 days.
Documents
Issuer
Coeptis Therapeutics Holdings, Inc.
CIK 0001759186
Entity typeother
Related Parties
1- filerCIK 0001824769
Filing Metadata
- Form type
- 4
- Filed
- Aug 30, 8:00 PM ET
- Accepted
- Aug 31, 4:01 PM ET
- Size
- 6.5 KB